AMALGAMATED BANK - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMALGAMATED BANK ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$161
-56.2%
7,8340.0%0.00%
-66.7%
Q2 2023$368
+60.7%
7,834
+43.6%
0.00%
+50.0%
Q1 2023$229
-13.9%
5,457
-21.6%
0.00%0.0%
Q4 2022$266
-99.9%
6,964
+3.5%
0.00%
-33.3%
Q3 2022$264,000
+24.5%
6,729
+2.4%
0.00%
+50.0%
Q2 2022$212,000
-28.6%
6,574
-26.8%
0.00%0.0%
Q1 2022$297,000
-62.4%
8,978
-51.7%
0.00%
-33.3%
Q4 2021$790,000
+4.5%
18,578
+8.9%
0.00%
-50.0%
Q3 2021$756,000
-24.2%
17,054
-2.8%
0.01%
-25.0%
Q2 2021$997,000
+113.9%
17,543
+182.0%
0.01%
-52.9%
Q1 2021$466,000
-19.1%
6,220
-6.6%
0.02%
-22.7%
Q4 2020$576,000
+41.2%
6,659
-0.3%
0.02%
+22.2%
Q3 2020$408,000
+46.8%
6,676
-0.0%
0.02%
+38.5%
Q2 2020$278,000
-27.4%
6,678
-49.9%
0.01%
+44.4%
Q1 2020$383,000
-60.8%
13,323
-1.7%
0.01%
-50.0%
Q4 2019$978,000
-44.8%
13,551
+7.3%
0.02%
-51.4%
Q3 2019$1,772,000
-13.1%
12,630
+13.3%
0.04%
-22.9%
Q2 2019$2,040,000
+16.1%
11,143
+0.9%
0.05%
+11.6%
Q1 2019$1,757,000
+80.4%
11,044
+8.6%
0.04%
+53.6%
Q4 2018$974,000
+10.6%
10,168
+63.0%
0.03%
+27.3%
Q3 2018$881,000
-47.0%
6,238
-41.3%
0.02%
-46.3%
Q2 2018$1,663,000
+83.6%
10,621
+88.9%
0.04%
+70.8%
Q1 2018$906,000
+6.8%
5,623
+9.2%
0.02%
+4.3%
Q4 2017$848,000
+209.5%
5,147
+16.9%
0.02%
+155.6%
Q3 2017$274,000
-21.5%
4,403
+0.6%
0.01%
-18.2%
Q2 2017$349,000
+33.2%
4,378
+18.6%
0.01%
-15.4%
Q1 2017$262,0003,6920.01%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders